VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, ...

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through ...

A high-level overview of Onco-Innovations Limited (ONCO:CA) stock. View (ONCO:CA) real-time stock price, chart, news, analysis, analyst reviews and more.

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq. Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a ...

Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value ...

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through pioneering ...

Onco-rheumatology is emerging as a vital transdisciplinary field, addressing the rising overlap of autoimmune diseases and ...

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025 ...

Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025 Provided by ACCESS Newswire Jun 25, 2025, 10:00:00 PM.